Research
We are driving the next generation of discoveries to address critical cancer challenges and accelerate the translation of scientific evidence into patient benefit.
Education
Fostering an outstanding cancer care workforce to help maintain and enhance world-leading patient outcomes through online learning, courses and events.
Health Equity
Pursuing equity in access to cancer care and outcomes for all Victorians affected by cancer.
Consumer Engagement
Partnering with consumers at every step of our journey, because no-one knows cancer like someone who’s lived it.
About Us
Research, academic and clinical institutions working together to accelerate cancer research, knowledge and expertise to benefit all.
News & Events
The VCCC Alliance brings you the latest in cancer research, education and clinical care through engaging, relevant and informative events.

Building Capability

Growth in capability enables our workforce to implement more cancer clinical trials in a broader range of disciplines.

Growth in Victoria’s clinical trial capability enables our workforce to implement more cancer clinical trials in a broader range of disciplines and previously underrepresented areas. As a result, cancer patients have access to a more diverse range of clinical trials, treatments and technologies.

These Building Trial Group Capability Programs advance knowledge and opportunity through:

  • leadership development for identified disciplines requiring progress
  • network creation for clinicians and healthcare professionals
  • training and mentoring for new investigators
  • clinical trial fellowships
  • resources and workforce development opportunities.

Proven infrastructure and governance delivers

Cancer clinical trials in Victoria are regularly conducted by VCCC Alliance partners, including Western Health, the Royal Children’s Hospital, the Royal Women’s Hospital, the Royal Melbourne Hospital, Peter MacCallum Cancer Centre, St Vincent’s Hospital and Austin Health.

This critical mass of successful clinical trial facilities and clinician researchers, have expertise across all phases of clinical trials, as well as proven infrastructure and established governance methods.

Expanding our clinical trials portfolio

To broaden and diversify clinical trials in Victoria, our activities aim to provide tailored pathways. Clinicians from cancer related disciplines, other than medical oncology and haematology, have lacked opportunities to develop the expertise required to develop and run clinical trials.

VCCC Alliance program champions are currently establishing clinical trials as routine practice within palliative care services. When feasible, this activity will be expanded into supportive care, surgical oncology, allied health, radiation oncology and other fields.

Clinical trial capability contact

Duncan Colyer
Program Manager: Clinical Trials Innovation
E [email protected]

Palliative care clinical trials, a high priority

Palliative care has a high level of community advocacy and a large patient pool and as such was selected as the first clinical discipline to be supported through this program.

Our alliance members’ clinical trials sites have leadership, expertise and experience in conducting a range of trials, encompassing areas such as cancer pain management, anorexia, cachexia, nausea and vomiting, constipation and breathlessness interventions.

The sites work collaboratively across Victoria to deliver quality clinical trials. A proven track record combined with excellent leadership has achieved rapid feasibility assessment, ethics and governance approval, as well as successful participant recruitment, all in the context of expert data management and reporting.

Palliative care clinical trials contacts

Professor Jennifer Philip
Chair of Palliative Medicine, University of Melbourne
Phone 03 9231 1267

Associate Professor Brian Le
Director Palliative Care, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital
Phone 03 8559 7960

Get the latest in cancer news, events and more, direct to your inbox

Join a network of Victorian cancer researchers, clinicians and consumers to keep your finger on the pulse.